Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases

被引：5

作者：

Donald, Alastair D. G. ^{[1
]}

Clark, Vanessa L. ^{[1
]}

Patel, Sanjay ^{[1
]}

Day, Francesca A. ^{[1
]}

Rowlands, Martin G. ^{[2
]}

Wibata, Judata ^{[2
]}

Stimson, Lindsay ^{[2
]}

Hardcastle, Anthea ^{[2
]}

Eccles, Sue A. ^{[2
]}

McNamara, Deborah ^{[1
]}

Needham, Lindsey A. ^{[1
]}

Raynaud, Florence I. ^{[2
]}

Aherne, Wynne ^{[2
]}

Moffat, David F. ^{[1
]}

机构：

[1] Chroma Therapeut, Abingdon OX14 4RY, Oxon, England

[2] Inst Canc Res, Canc Res UK Canc Therapeut Unit, Surrey SM2 5NG, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 22期

关键词：

HDAC; Cancer; Optimisation; PROMISE;

D O I：

10.1016/j.bmcl.2010.09.016

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibition of histone deacetylase activity represents a promising new modality in the treatment of a number of cancers. A novel HDAC series demonstrating inhibitory activity in cell proliferation assays is described. Optimisation based on the introduction of basic amine linkers to effect good drug distribution to tumour led to the identification of a compound with oral activity in a human colon cancer xenograft study associated with increased histone H3 acetylation in tumour tissue. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：6657 / 6660

页数：4

共 50 条

[21] Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors
Terracciano, Stefania
Chini, Maria Giovanna
Riccio, Raffaele
Bruno, Ines
Bifulco, Giuseppe
CHEMMEDCHEM, 2012, 7 (04) : 694 - 702
[22] Computational Studies on the Histone Deacetylases and the Design of Selective Histone Deacetylase Inhibitors
Wang, Difei
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (03) : 241 - 256
[23] The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE
Levin, JI
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (12) : 1289 - 1310
[24] Design, Synthesis, and Biological Evaluation of Vanillin Hydroxamic Acid Derivatives as Novel Peptide Deformylase Inhibitors
Gao, Jian
Qiu, Shengzhi
Liang, Li
Hao, Zhixiang
Zhou, Qianqian
Wang, Fanfan
Mou, Jie
Lin, Qisi
CURRENT COMPUTER-AIDED DRUG DESIGN, 2018, 14 (01) : 95 - 101
[25] Design, synthesis and biological evaluation of novel imidazole-based benzamide and hydroxamic acid derivatives as potent histone deacetylase inhibitors and anticancer agents
Nasrollahzadeh, Mahda Sadat
Eskandarpour, Vahid
Maleki, Mahdi Faal
Eisvand, Farhad
Mashreghi, Mohammad
Hadizadeh, Farzin
Tayarani-Najaran, Zahra
Ghodsi, Razieh
JOURNAL OF MOLECULAR STRUCTURE, 2024, 1297
[26] Design, synthesis and biological evaluation of pyrimidine base hydroxamic acid derivatives as dual JMJD3 and HDAC inhibitors
Li, Anqi
Zheng, Wenwen
Xiao, Boren
Huang, Wenjun
Li, Lulu
Luo, Minglang
Liu, Zijian
Chu, Bizhu
Jiang, Yuyang
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 94
[27] Synthesis and biological evaluation of novel histone deacetylases inhibitors with nitric oxide releasing activity
Duan, Wenwen
Hou, Jinning
Chu, Xiaojing
Li, Xiaoqian
Zhang, Jian
Li, Jin
Xu, Wenfang
Zhang, Yingjie
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) : 4481 - 4488
[28] Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)
Schaefer, Stefan
Saunders, Laura
Eliseeva, Elena
Velena, Alfredo
Jung, Mira
Schwienhorst, Andreas
Strasser, Anja
Dickmanns, Achim
Ficner, Ralf
Schlimme, Sonja
Sippl, Wolfgang
Verdin, Eric
Jung, Manfred
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (04) : 2011 - 2033
[29] Inhibitors of histone-deacetylases
Pelicci, PG
TUMORI, 2001, 87 (06) : S12 - S14
[30] Hydrazides as Inhibitors of Histone Deacetylases
Carreiras, Maria do Carmo
Marco-Contelles, Jose
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 13512 - 13533

← 1 2 3 4 5 →